Search

everythinglearnresearchcommunity

for

Search:↓

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Polarized microscopy is a quick and free method to correctly identify types of hair loss.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Trichoscopy is crucial for diagnosing and assessing alopecia areata in children.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.